Tricol Biomedical, INC
At a glance
Employees1-19
In business since2001
HeadquartersPortland, OR
US patents13
SAM.gov UEIJG5HB91R2FB4
CAGE code1UXC2
Incorporated inOR
- devices
- hemostasis
- wound care management
- HemCon product line
- trauma management
- procedural care
- consumer self-care
- dressings
Named on the company’s own website, read JUL 29, 2026
What they make
Clamp, VascularHemostatic Wound Dressing Without Thrombin Or Other BiologicsOral Wound DressingSplint, Intranasal SeptalTape And Bandage, Adhesive
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
13 US patents granted 2017–2024, 7 of them in the five years to SEP 2025.
Pharmaceuticals 9Medical technology 4
- Chitosan dressing for control of bleeding in transurethral prostatectomyUS 12,156,791 · granted DEC 3, 2024
- Chitosan superfine fiber systemsUS 11,890,384 · granted FEB 6, 2024
- Delivery systems for control of bleeding in transurethral prostatectomyUS 11,660,236 · granted MAY 30, 2023
- Delivery systems for control of gastrointestinal bleedingUS 11,564,673 · granted JAN 31, 2023
- Chitosan materials from carbonic acid solutionUS 11,234,998 · granted FEB 1, 2022
Newest 5 shown · Granted to Tricol Biomedical, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Tricol Biomedical, INC | Portland | OR | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.